Delta4: using AI to tap into the pentabytes of available data to de-risk pharma decisions. Delta4 is a TechBio company focused on helping clients expand indications for existing drugs with known safety profiles. By leveraging Hyper-C, a proprietary artificial intelligence-powered platform, the team of computational biologists at Delta4 detects beneficial drug-indication relationships with unprecedented speed, accuracy, and efficiency.
Services:Delta4 helps pharma in: - Finding new indications for existing drugs - Identifying new drug targets in diseases of interest - Exploring drug combinations - Identifying and ranking disease-modifying drug targets - Discovering prognostic and predictive biomarkers to identify responders - Providing insights into downstream consequences - Assessing the side effects of a compound or the modulation of a drug target in a disease